Acura Pharmaceuticals announces financial results

Palatine-based Acura Pharmaceuticals Inc. reported a net loss of $1.2 million, or 4 cents per diluted share, for its fiscal year ended Dec. 31, compared to a net loss of $3.8 million, or 14 cents per diluted share, for the same period in 2019.

Related posts